Subscription and Copyright Information
One-time access price info For academic or personal research use, select ‘Academic and Personal’ For corporate R &D use, select ‘Corporate R &D Professionals’ Already an online subscriber?
One-time access price info For academic or personal research use, select ‘Academic and Personal’ For corporate R &D use, select ‘Corporate R &D Professionals’ Already an online subscriber?
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…
Nature Reviews Immunology – Compared with many other vaccines, current vaccines against influenza provide only limited protection. Here, the authors describe the challenges and recent…
Nature Reviews Immunology – An optimal immune response to influenza virus strikes a balance between protective antiviral immune mechanisms and detrimental immunopathology. Here, the authors…
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women…
Adult humans with inherited, complete FLT3L deficiency enable valuable insights into the role of the hematopoietic growth factor FLT3L in human hematopoiesis, revealing that FLT3L…
Despite the relative noisiness of polygenic indexes (PGIs), some commercial firms will use them. We offer a simple model, rooted in economic theory, to show…
To accelerate CRISPR-based targeting of RNA, Guo et al. present a resource with optimized RfxCas13d guide RNAs (gRNAs) to target messenger RNAs and noncoding RNAs in…
The AAAAI offers articles written and reviewed by experts on asthma and spirometry.
Oligodendrocytes in multiple sclerosis lesions exhibit epigenetic silencing that precludes myelin restoration. This study identifies a small-molecule inhibitor that counteracts epigenetic silencing, effectively enhancing myelin…
As immunotherapy makes its way into the perioperative setting, a growing number of clinical trials are expanding the evidence base for resectable non-small cell lung…